Chemours (NYSE: CC) has recently received a number of price target changes and ratings updates:
- 11/18/2026 – Chemours was downgraded by Weiss Ratings from “sell (d-)” to “sell (e+)”.
- 11/9/2026 – Chemours had its price target lowered by JPMorgan Chase & Co. from $15.00 to $14.00. They now have a “neutral” rating on the stock.
- 11/4/2026 – Chemours was downgraded by Zacks Research from “hold” to “strong sell”.
- 11/4/2026 – Chemours had its price target lowered by UBS Group from $16.00 to $15.00. They now have a “neutral” rating on the stock.
- 11/4/2026 – Chemours had its price target lowered by Truist Financial from $20.00 to $18.00. They now have a “buy” rating on the stock.
- 11/3/2026 – Chemours had its “sell (d-)” rating reaffirmed by Weiss Ratings.
- 10/20/2026 – Chemours had its price target lowered by Truist Financial from $24.00 to $20.00. They now have a “buy” rating on the stock.
- 10/14/2026 – Chemours was downgraded by Mizuho from “outperform” to “neutral”. They now have a $15.00 price target on the stock, down from $18.00.
- 10/13/2026 – Chemours was downgraded by Royal Bank Of Canada from “outperform” to “sector perform”. They now have a $14.00 price target on the stock.
- 10/13/2026 – Chemours was downgraded by Mizuho from “strong-buy” to “hold”.
- 10/12/2026 – Chemours is now covered by Barclays. They set an “equal weight” rating and a $16.00 price target on the stock.
- 10/12/2026 – Chemours was upgraded by Barclays to “hold”.
- 10/9/2026 – Chemours had its “neutral” rating reaffirmed by The Goldman Sachs Group. They now have a $16.00 price target on the stock.
- 10/5/2026 – Chemours had its price target lowered by UBS Group from $18.00 to $16.00. They now have a “neutral” rating on the stock.
- 9/30/2026 – Chemours had its price target lowered by Mizuho from $20.00 to $18.00. They now have an “outperform” rating on the stock.
Chemours Stock Down 2.1%
NYSE CC traded down $0.25 on Friday, hitting $11.55. The stock had a trading volume of 147,859 shares, compared to its average volume of 2,784,960. The business’s fifty day moving average price is $13.50 and its 200 day moving average price is $18.09. The stock has a market cap of $1.74 billion, a price-to-earnings ratio of -11.32 and a beta of 1.47. The company has a debt-to-equity ratio of 24.25, a current ratio of 1.81 and a quick ratio of 0.98. The Chemours Company has a 52-week low of $10.51 and a 52-week high of $28.67.
Chemours (NYSE:CC – Get Free Report) last issued its quarterly earnings data on Monday, November 2nd. The specialty chemicals company reported $0.21 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.05). Chemours had a negative net margin of 2.64% and a positive return on equity of 76.52%. The business had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter in the prior year, the company posted $0.40 EPS. The business’s revenue for the quarter was up 3.0% on a year-over-year basis. Equities research analysts anticipate that The Chemours Company will post 0.80 earnings per share for the current year.
Chemours Announces Dividend
The Chemours Company is a global chemicals manufacturer spun off from DuPont in 2015 and headquartered in Wilmington, Delaware. It develops and produces materials used in industries ranging from construction and transportation to electronics and energy. Chemours’ Titanium Technologies business makes titanium dioxide (TiO₂) pigment, sold under the Ti-Pure brand, which is used to add whiteness, brightness and opacity to products such as paints, coatings, plastics and paper. Its Thermal & Specialized Solutions business supplies refrigerants, foam-blowing agents and other specialty fluids, including products marketed under the Opteon and Freon brands.
Read More
- Five stocks we like better than Chemours
- Palo Alto Networks’ Q1 Beat Gives Its Stock Rally Another Reason to Run
- Airfares Are Up, Flights Are Tight: 3 Airline Stocks Facing a Winter Test
- Hard Drives Were Left for Dead, But Seagate and Western Digital Are Soaring
- Tesla and SpaceX May Form a $3.4 Trillion Giant, But Who Really Benefits?
Receive News & Ratings for The Chemours Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Chemours Company and related companies with MarketBeat.com's FREE daily email newsletter.
